ALLO Allogene Therapeutics, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Allogene Therapeutics (ALLO) Stock: Buy, Sell, or Hold?

$0.90
-0.03 (-3.41%) β–Ό
5d: -24.36% 30d: -30.22% 90d: -54.54%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
40/100
Position
OVERSOLD
30-Day Fair Range
$1.10 – $1.40
Position: OVERSOLD
Forward P/E & Valuation
-1.5x
Next 12M consensus est.
Wall Street Target
$9.00
+899.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.88 / $1.38
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ALLO is down 24.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When ALLO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ALLO is currently trading at $0.90, which is considered oversold relative to its 30-day fair value range of $1.10 to $1.40.

Technical Outlook: Technically, ALLO is in a strong downtrend. The price is currently testing key support at $0.88. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.

Market Sentiment: ALLO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.00 (+899.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.10 - $1.40
Company Quality Score 40/100 (SELL)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $1.10 - $1.40
Current vs Trading Range OVERSOLD
Support Level $0.88
Resistance Level $1.38
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.4%)
  • BULLISH: Trading 899.9% below Wall St target ($9.00)
  • WARNING: Composite score 40/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.47
Wall Street Target $9.00 (+899.9%)
Revenue Growth (YoY) -100.0%
Share ALLO Analysis

Share this live ALLO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ALLO)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user maintains that the $ALLO stock price drop is not indicative of a fundamental change in the Alpha 3 story, but rather an opportunity for investors.
Key Retail Themes: Stock price drop Confidence in Alpha 3 story
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:12 PM ET
Data refreshes hourly during market hours. Next update: 11:12 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ALLO.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 31 SELL
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 35 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 62 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 41 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ALLO Research Pages
ALLO Technical Chart ALLO Price Prediction ALLO Intrinsic Value DCF ALLO Earnings Date ALLO Investment Advisor ALLO Fair Price Analyzer ALLO Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals